BlueMountain Increases Activist Stake in Eastman Kodak to 20% of Company

Eastman Kodak Company, BlueMountain: In filing with the SEC from a couple of minutes ago, BlueMountain Capital Management managed by Andrew Feldstein and Stephen Siderow, reported increasing its position in Eastman Kodak Company (OTCMKTS:EKDKQ), now holding 20.2% of the company, from 19.2% reported at the beginning of September. BlueMountain disclosed ownership of some 7.88 millioh shares of Eastman Kodak, the value of the position rising to almost $237,800.

Andrew Feldstein and Stephen Siderow

At the beginning of September, Eastman Kodak emerged from Chapter 11 after the court confirmed its plan of reorganization. The restructuring of the company involved the spin-off of Kodak’s Personalized Imaging and Document Imaging businesses to Kodak Pension Plan, a long-standing pension fund of its U.K. subsidiary. Also, Kodak conducted a rights offering gaining over $400 million of new equity investments, the company said in a statement.

Disclosure: none

Recommended Reading:

Blackstone Reports $34M Worth of Eastman Kodak Warrants

Why Investing Like This Activist Could Make You Look Smart

How to Play Merger Arbitrage Cliff Asness Style

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!